• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacokinetic study of cytosine arabinoside in patients with acute myelogeneous leukemia.

作者信息

Preusser P, Pielken H J, Bauch H J

出版信息

Haematol Blood Transfus. 1987;30:288-92. doi: 10.1007/978-3-642-71213-5_43.

DOI:10.1007/978-3-642-71213-5_43
PMID:3476359
Abstract
摘要

相似文献

1
Pharmacokinetic study of cytosine arabinoside in patients with acute myelogeneous leukemia.急性髓细胞白血病患者阿糖胞苷的药代动力学研究
Haematol Blood Transfus. 1987;30:288-92. doi: 10.1007/978-3-642-71213-5_43.
2
Fulminant hepatic failure after high-dose cytosine arabinoside and mitoxantrone treatment for relapse of acute myelogenous leukaemia.高剂量阿糖胞苷和米托蒽醌治疗急性髓性白血病复发后出现暴发性肝衰竭。
Eur J Haematol. 1992 Oct;49(4):221-3. doi: 10.1111/j.1600-0609.1992.tb00052.x.
3
Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM).将复发和难治性急性髓细胞白血病分类的提议，作为对序贯应用大剂量与中剂量阿糖胞苷联合米托蒽醌（S-HAM）进行年龄调整随机比较的基础。
Haematol Blood Transfus. 1990;33:604-10. doi: 10.1007/978-3-642-74643-7_110.
4
High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.大剂量阿糖胞苷联合米托蒽醌治疗难治性急性髓系白血病和急性淋巴细胞白血病
Semin Oncol. 1987 Jun;14(2 Suppl 1):73-7.
5
[Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
Bull Cancer. 1974 Jul-Sep;61(3):411-8.
6
Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.阿糖胞苷联合米托蒽醌或柔红霉素用于既往未经治疗的成年急性非淋巴细胞白血病（ANLL）患者的随机多中心试验。莱德利协作组。
Leukemia. 1990 Mar;4(3):177-83.
7
[Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].[莫拉司亭（粒细胞-巨噬细胞集落刺激因子）用于急性白血病患者的研究]
Wiad Lek. 1995 Jan-Jun;48(1-12):194-7.
8
6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.6-硫鸟嘌呤、阿糖胞苷和柔红霉素（TAD）以及高剂量阿糖胞苷和米托蒽醌（HAM）用于诱导治疗，TAD用于巩固治疗，对于各年龄段初发急性髓系白血病（AML）的成年患者，采用每月减量的TAD进行长期维持治疗或TAD-HAM-TAD方案，以及通过序贯HAM进行一个疗程的强化巩固治疗：德国AML协作组的一项随机试验
J Clin Oncol. 2003 Dec 15;21(24):4496-504. doi: 10.1200/JCO.2003.02.133.
9
Remission induction with cytarabine and daunorubicin with or without 6-thioguanine in adult patients with acute myelocytic leukemia.阿糖胞苷和柔红霉素联合或不联合6-硫鸟嘌呤用于成年急性髓细胞白血病患者的缓解诱导治疗。
Haematol Blood Transfus. 1987;30:352-5. doi: 10.1007/978-3-642-71213-5_57.
10
Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
Recent Results Cancer Res. 1973;43:165-8.